Discover

NAMS
NewAmsterdam Pharma Company N.V.
35.17
2 x 25.05
2 x 43.94
bid
ask
+
1.28
3.78%
2 @ 07:03 AM
35.18 +0.01 (0.03%)
Ytd0.26%
1y93.03%
34.06
day range
35.40
18.07
52 week range
42.20
Open34.33Prev Close33.89Low34.06High35.40Mkt Cap4.11B
Vol867.67KAvg Vol1.29MEPS-1.78P/EN/AForward P/E-27.63
Beta0.08Short Ratio7.09Inst. Own106.19%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg32.68200-d Avg33.561yr Est49.46

NAMS News

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026
globenewswire.com
NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Co

NAARDEN, the Netherlands and MIAMI, July 01, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.

benzinga.com
RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Raises Price Target to $51

RBC Capital analyst Leonid Timashev maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Outperf

Monster Beverage, Westrock Coffee, Himax Technologies And Other Big Stocks Moving Higher On Friday
benzinga.com
Monster Beverage, Westrock Coffee, Himax Technologies And Other Big Stocks Moving Higher On Friday

US stocks, including Monster Beverage Corp, rose on Friday. Monster Beverage reported better-than-ex

benzinga.com
NewAmsterdam Pharma Q1 EPS $(0.40) Beats $(0.47) Estimate, Sales $3.040M Beat $936.364K Estimate

NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.40) per share which beat the anal

benzinga.com
Guggenheim Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $45

Guggenheim analyst Debjit Chattopadhyay maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy

Forecasting The Future: 4 Analyst Projections For NewAmsterdam Pharma Co
benzinga.com
Forecasting The Future: 4 Analyst Projections For NewAmsterdam Pharma Co

benzinga.com
Needham Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $48

Needham analyst Serge Belanger maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy and rais

Earnings Summary: NewAmsterdam Pharma Co Q4
benzinga.com
Earnings Summary: NewAmsterdam Pharma Co Q4

Assessing NewAmsterdam Pharma Co: Insights From 5 Financial Analysts
benzinga.com
Assessing NewAmsterdam Pharma Co: Insights From 5 Financial Analysts

benzinga.com
RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Raises Price Target to $47

RBC Capital analyst Leonid Timashev maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Outperf

benzinga.com
NewAmsterdam Pharma Issues Update On Obicetrapib Clinical Development Program And Outlines Strategic

-- EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26

benzinga.com
Stifel Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $50

Stifel analyst James Condulis maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy and raise

benzinga.com
Goldman Sachs Maintains Neutral on NewAmsterdam Pharma Co, Raises Price Target to $37

Goldman Sachs analyst Asad Haider maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Neutral

benzinga.com
RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Raises Price Target to $44

RBC Capital analyst Leonid Timashev maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Outperf

benzinga.com
Needham Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $46

Needham analyst Serge Belanger maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy and rais

benzinga.com
NewAmsterdam Pharma Q3 EPS $(0.61) Misses $(0.41) Estimate, Sales $348.000K Miss $5.287M Estimate

NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.61) per share which missed the an

benzinga.com
Deep Dive Into NewAmsterdam Pharma Co Stock: Analyst Perspectives (4 Ratings)

benzinga.com
HC Wainwright & Co. Assumes NewAmsterdam Pharma Co at Buy, Announces Price Target of $52

HC Wainwright & Co. analyst Joseph Pantginis assumes NewAmsterdam Pharma Co (NASDAQ:NAMS) wit

benzinga.com
Citigroup Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $50

Citigroup analyst Geoff Meacham maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy and rai

benzinga.com
Expert Outlook: NewAmsterdam Pharma Co Through The Eyes Of 6 Analysts

benzinga.com
Wells Fargo Initiates Coverage On NewAmsterdam Pharma Co with Overweight Rating, Announces Price Tar

Wells Fargo analyst Yanan Zhu initiates coverage on NewAmsterdam Pharma Co (NASDAQ:NAMS) with a O

benzinga.com
NewAmsterdam Pharma And Piramal Pharma Solutions Invest Multi-Million Dollars In Dedicated Oral Soli

The multi-million-dollar investment provides NewAmsterdam Pharma with commercial capacity for fixed

benzinga.com
What 5 Analyst Ratings Have To Say About NewAmsterdam Pharma Co

benzinga.com
RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Raises Price Target to $39

RBC Capital analyst Leonid Timashev maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Outperf

benzinga.com
NewAmsterdam Pharma Q2 EPS $(0.15) Beats $(0.46) Estimate, Sales $19.145M Beat $2.235M Estimate

NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.15) per share which beat the anal

benzinga.com
NewAmsterdam's Obicetrapib Reduces Alzheimer's Biomarker p-tau217 In High-Risk ApoE4 Carriers, Suppo

-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217

benzinga.com
'Biotech Says Its Cholesterol Drug Shows Signs Of Preventing Alzheimer's; NewAmsterdam Pharma Hopes

https://www.statnews.com/2025/07/30/new-amsterdam-pharma-cholesterol-drug-alzheimers/

benzinga.com
Goldman Sachs Initiates Coverage On NewAmsterdam Pharma Co with Neutral Rating, Announces Price Targ

Goldman Sachs analyst Asad Haider initiates coverage on NewAmsterdam Pharma Co (NASDAQ:NAMS) wit

benzinga.com
Citigroup Initiates Coverage On NewAmsterdam Pharma Co with Buy Rating, Announces Price Target of $4

Citigroup analyst Geoff Meacham initiates coverage on NewAmsterdam Pharma Co (NASDAQ:NAMS) with a

benzinga.com
What Analysts Are Saying About NewAmsterdam Pharma Co Stock

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premark

Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market

benzinga.com
United Natural Foods Posts Upbeat Results, Joins Alphabet, Ollie's Bargain, MoneyLion And Other Big

benzinga.com
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Fri

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCo

benzinga.com
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company rep

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mi

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire

benzinga.com
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mi

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Tech

benzinga.com
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving I

Gainers

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 89 companies set new 52-week lows.